Fayçal Mouaffak

1.5k total citations
31 papers, 492 citations indexed

About

Fayçal Mouaffak is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Fayçal Mouaffak has authored 31 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 6 papers in Pharmacology. Recurrent topics in Fayçal Mouaffak's work include Schizophrenia research and treatment (11 papers), Electroconvulsive Therapy Studies (6 papers) and Mental Health Treatment and Access (3 papers). Fayçal Mouaffak is often cited by papers focused on Schizophrenia research and treatment (11 papers), Electroconvulsive Therapy Studies (6 papers) and Mental Health Treatment and Access (3 papers). Fayçal Mouaffak collaborates with scholars based in France, United States and Canada. Fayçal Mouaffak's co-authors include Marie‐Odile Krebs, Oussama Kébir, Jean‐Pierre Olié, Marie‐France Poirier, Raphaël Gourévitch, Constantin Tranulis, David Gourion, S. Douki, J.-P. Olié and Bruno Millet and has published in prestigious journals such as Psychological Medicine, Molecular Psychiatry and Psychiatry Research.

In The Last Decade

Fayçal Mouaffak

30 papers receiving 471 citations

Peers

Fayçal Mouaffak
Yakup Albayrak Türkiye
Raphaël Gourévitch France
Dana D. Nguyen United States
Concetta Petruzzi Italy
Tomoyuki Nagata Japan
Erlend Strand Gardsjord Norway
Marina Mihaljević Serbia
Efrat Kravitz Israel
Kazuto Oya Japan
Ida S. Haussleiter Germany
Yakup Albayrak Türkiye
Fayçal Mouaffak
Citations per year, relative to Fayçal Mouaffak Fayçal Mouaffak (= 1×) peers Yakup Albayrak

Countries citing papers authored by Fayçal Mouaffak

Since Specialization
Citations

This map shows the geographic impact of Fayçal Mouaffak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fayçal Mouaffak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fayçal Mouaffak more than expected).

Fields of papers citing papers by Fayçal Mouaffak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fayçal Mouaffak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fayçal Mouaffak. The network helps show where Fayçal Mouaffak may publish in the future.

Co-authorship network of co-authors of Fayçal Mouaffak

This figure shows the co-authorship network connecting the top 25 collaborators of Fayçal Mouaffak. A scholar is included among the top collaborators of Fayçal Mouaffak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fayçal Mouaffak. Fayçal Mouaffak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bellon, Alfredo, Vincent Feuillet, Fayçal Mouaffak, et al.. (2022). Dopamine-induced pruning in monocyte-derived-neuronal-like cells (MDNCs) from patients with schizophrenia. Molecular Psychiatry. 27(6). 2787–2802. 14 indexed citations
3.
4.
Mouaffak, Fayçal, Florian Ferreri, Olivier Blin, et al.. (2021). Dosing antipsychotics in special populations of patients with schizophrenia: severe psychotic agitation, first psychotic episode and elderly patients. Expert Opinion on Pharmacotherapy. 22(18). 2507–2519. 2 indexed citations
5.
Sousa, Caren Nádia Soares de, Luna Costa Vasconcelos, Fayçal Mouaffak, et al.. (2018). Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review. Metabolic Brain Disease. 34(1). 39–52. 34 indexed citations
6.
Sousa, Caren Nádia Soares de, Germana Silva Vasconcelos, Fayçal Mouaffak, et al.. (2018). Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(8). 803–817. 17 indexed citations
7.
Bellon, Alfredo, Amélie Wegener, Michael Valente, et al.. (2018). Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming. Frontiers in Molecular Neuroscience. 11. 323–323. 14 indexed citations
8.
Mouaffak, Fayçal, et al.. (2017). Le microbiote intestinal : un nouvel acteur de la dépression ?. L Encéphale. 44(1). 67–74. 3 indexed citations
9.
Hardy, P., et al.. (2016). La veille sanitaire dans la prise en charge des suicidants. Quels outils, quels effets, comment les évaluer ?. L Encéphale. 43(1). 75–80. 4 indexed citations
10.
Mouaffak, Fayçal, et al.. (2015). OSTA program: A French follow up intervention program for suicide prevention. Psychiatry Research. 230(3). 913–918. 17 indexed citations
11.
Mouaffak, Fayçal, et al.. (2014). Capgras’ and Cotard’s Delusions Associated With a Particular Pattern of Cerebral Activity in a Severely Depressed Patient. The Primary Care Companion For CNS Disorders. 16(4). 2 indexed citations
12.
Mouaffak, Fayçal, et al.. (2014). Electroconvulsivotherapy Augmentation With Folate in the Treatment of a Resistant Depression. Clinical Neuropharmacology. 37(5). 158–159. 5 indexed citations
13.
Sentissi, Othman, et al.. (2013). Intérêt de l’électroconvulsivothérapie de maintenance dans les troubles de l’humeur. L Encéphale. 39(5). 367–373. 1 indexed citations
14.
Gaillard, Raphaël, et al.. (2011). Traitement par électroconvulsivothérapie d’une tétraplégie par conversion hystérique : à propos d’un cas. L Encéphale. 38(1). 104–109. 9 indexed citations
15.
Mouaffak, Fayçal, Oussama Kébir, Sylvie Tordjman, et al.. (2010). Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophrenia. The Pharmacogenomics Journal. 11(4). 267–273. 35 indexed citations
16.
Dubois, Olivier, Roger Salamon, Christine Germain, et al.. (2010). Balneotherapy versus paroxetine in the treatment of generalized anxiety disorder. Complementary Therapies in Medicine. 18(1). 1–7. 47 indexed citations
17.
Mouaffak, Fayçal, Yannick Morvan, M.-C. Bourdel, et al.. (2009). Validation de la version française de l’échelle abrégée d’appréciation psychiatrique étendue avec ancrage, BPRS-E(A). L Encéphale. 36(4). 294–301. 22 indexed citations
18.
Mouaffak, Fayçal, et al.. (2009). Les schizophrénies, maladies du neurodéveloppement. Annales Pharmaceutiques Françaises. 67(4). 251–255. 3 indexed citations
19.
Fatjó‐Vilas, Mar, et al.. (2008). New evidences of gene and environment interactions affecting prenatal neurodevelopment in schizophrenia-spectrum disorders: A family dermatoglyphic study. Schizophrenia Research. 103(1-3). 209–217. 29 indexed citations
20.
Mouaffak, Fayçal, Constantin Tranulis, Raphaël Gourévitch, et al.. (2006). Augmentation Strategies of Clozapine With Antipsychotics in the Treatment of Ultraresistant Schizophrenia. Clinical Neuropharmacology. 29(1). 28–33. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yakup Albayrak Breakdown of academic impact, for papers by Raphaël Gourévitch Breakdown of academic impact, for papers by Dana D. Nguyen Breakdown of academic impact, for papers by Concetta Petruzzi Breakdown of academic impact, for papers by Tomoyuki Nagata Breakdown of academic impact, for papers by Erlend Strand Gardsjord Breakdown of academic impact, for papers by Marina Mihaljević Breakdown of academic impact, for papers by Efrat Kravitz Breakdown of academic impact, for papers by Kazuto Oya Breakdown of academic impact, for papers by Ida S. Haussleiter
Rankless by CCL
2026